[The intermediate substance of the aorta in dissecting aneurysm in comparison with various diseases].
D001011:Aorta / Q000032:analysis*; D001014:Aortic Aneurysm / Q000150:complications / Q000378:metabolism*; D001018:Aortic Diseases / Q000378:metabolism*; D001019:Aortic Rupture / Q000209:etiology; D001161:Arteriosclerosis / Q000378:metabolism; D001344:Autopsy; D002305:Cardiac Tamponade / Q000209:etiology; D002807:Chondroitin / Q000032:analysis*; D003480:Cushing Syndrome / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000378:metabolism; D005260:Female; D006025:Glycosaminoglycans / Q000032:analysis*; D006493:Heparin / Q000032:analysis*; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis*; D006980:Hyperthyroidism / Q000378:metabolism; D007037:Hypothyroidism / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D013431:Sulfates / Q000032:analysis; D013589:Syphilis, Cardiovascular / Q000378:metabolism
D006025:Glycosaminoglycans; D013431:Sulfates; D006820:Hyaluronic Acid; D006493:Heparin; D002807:Chondroitin
Untersuchung über die Intermediärsubstanz der Aorta bei Aneurysma dissecans im Vergleich zu anderen Krankheitsbildern.